UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 31, 2004
BRISTOL-MYERS SQUIBB COMPANY
(Exact name of registrant as specified in its charter)
| Delaware (State or other jurisdiction of incorporation) |
1-1136 (Commission file number) |
2-079-0359 (IRS employer identification number) |
345 Park Avenue
New York, NY 10154
(Address of Principal Executive Office)
Registrant's telephone number, including area code: (212) 546-4000
Incorporated by reference in its entirety is a press release issued by the registrant on March 31, 2004, attached as exhibit 99, concerning the registrant's statement regarding Paraplatin® pediatric submission and federal appeals court reversal on patent.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements
Inapplicable.
(b) Pro Forma Financial Information
Inapplicable.
(c) Exhibit.
99 Press Release dated March 31, 2004.
2
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BRISTOL-MYERS SQUIBB COMPANY |
||||
By: |
/s/ SANDRA LEUNG Name: Sandra Leung Title: Corporate Secretary |
|||
3
| Exhibit No. |
Description of the Exhibit |
|
|---|---|---|
99 |
Press Release dated March 31, 2004 |